PB301 Target Overview
Limitations of stem cell therapy
Possibility of stem cell therapy using exosomes
MoA & Indication of PB301
- Various Th17 cell targeting treatments using MSC-exosomes
- Target : Th17 cell
- MoA :
- Autoimmune disease
Th17 cell-mediated autoimmune disease
Domestic patent registration
Human neural stem cell-derived immunomodulatory microvesicles and uses thereof.
Treatment of autoimmune diseases involving MSC-exosomes.